Hair Loss
17
 min read

Does Diabetes Cause Hair Loss? Causes, Treatments and NHS Advice

Written by
Bolt Pharmacy
Published on
13/3/2026

Does diabetes cause hair loss? Whilst hair loss is not a primary symptom of diabetes, there is a recognised clinical association between the two conditions. Both type 1 and type 2 diabetes can create physiological disruptions — including poor circulation, oxidative stress, hormonal imbalance, and nutritional deficiencies — that may interfere with the normal hair growth cycle. Understanding the mechanisms behind this link, and knowing when to seek medical advice, can help people with diabetes take proactive steps to protect their hair health and overall wellbeing.

Summary: Diabetes does not directly cause hair loss, but poorly controlled blood sugar, microvascular damage, hormonal disruption, and associated conditions can disrupt the hair growth cycle and lead to increased shedding.

  • Both type 1 and type 2 diabetes can contribute to hair loss through multiple mechanisms, including impaired circulation, oxidative stress, and insulin resistance.
  • Telogen effluvium — diffuse, stress-related shedding — is the most common hair loss pattern associated with diabetes and is often reversible once the underlying trigger is addressed.
  • Type 1 diabetes increases the risk of autoimmune conditions such as alopecia areata and thyroid dysfunction, both of which can cause significant hair loss.
  • Long-term metformin use can reduce vitamin B12 absorption; the MHRA recommends monitoring B12 levels in patients on metformin, as deficiency is linked to hair thinning.
  • GLP-1 receptor agonists such as semaglutide list alopecia as an adverse reaction, and rapid weight loss associated with these treatments can also trigger telogen effluvium.
  • Optimising glycaemic control in line with NICE guidelines (NG28 and NG17) is the most important step in addressing diabetes-related hair loss.
GLP-1

Wegovy®

A weekly GLP-1 treatment proven to reduce hunger and support meaningful, long-term fat loss.

  • ~16.9% average body weight loss
  • Boosts metabolic & cardiovascular health
  • Proven, long-established safety profile
  • Weekly injection, easy to use
GLP-1 / GIP

Mounjaro®

Dual-agonist support that helps curb appetite, hunger, and cravings to drive substantial, sustained weight loss.

  • ~22.5% average body weight loss
  • Significant weight reduction
  • Improves blood sugar levels
  • Clinically proven weight loss

How Diabetes Can Contribute to Hair Loss

Diabetes does not directly cause hair loss, but poorly controlled blood glucose can create metabolic, circulatory, and immune disruptions that interfere with the hair growth cycle.

Diabetes is a long-term metabolic condition that affects how the body regulates blood glucose. Whilst hair loss is not a primary symptom of diabetes, associations between the two conditions have been observed clinically. Both type 1 and type 2 diabetes can, over time, create physiological conditions that may disrupt the normal hair growth cycle, though the relationship is not universal or directly causal in most cases.

Hair follicles are highly sensitive to changes in the body's internal environment. They require a consistent supply of oxygen, nutrients, and hormonal signals to progress through their natural growth phases — anagen (growth), catagen (transition), and telogen (resting/shedding). When diabetes is poorly controlled, several mechanisms may interfere with this cycle, potentially leading to increased shedding or slowed regrowth.

It is important to note that hair loss in people with diabetes is rarely caused by a single factor. Rather, it tends to result from a combination of metabolic, circulatory, and immune-related disruptions. Understanding these contributing factors can help patients and clinicians address the underlying causes rather than treating hair loss in isolation. If you have diabetes and are noticing significant hair thinning, it is worth discussing this with your GP or diabetes care team, as it may signal that your condition requires closer management.

Further information: NHS: Hair loss (Alopecia); NICE CKS: Telogen effluvium; Diabetes UK: Diabetes and associated health conditions.

Contributing Factor Mechanism Type of Hair Loss Key Action / Investigation
Poor glycaemic control / microvascular disease Reduced blood flow to scalp; oxidative stress damages follicle cells Diffuse thinning; telogen effluvium Optimise HbA1c per NICE NG28 / NG17
Insulin resistance / elevated androgens Raised DHT levels (especially in PCOS) drive follicle miniaturisation Androgenetic alopecia (pattern hair loss) Check androgens, SHBG; consider topical minoxidil if confirmed
Autoimmune activity (type 1 diabetes) Immune system attacks hair follicles; co-occurrence with other autoimmune conditions Alopecia areata (patchy loss) Dermatology referral; topical or intralesional corticosteroids
Thyroid dysfunction Higher prevalence of Hashimoto's thyroiditis in type 1 diabetes; hypo/hyperthyroidism disrupts follicle cycle Diffuse hair loss Check TSH, free T4; treat underlying thyroid condition
Vitamin B12 deficiency (metformin use) Long-term metformin reduces B12 absorption; B12 deficiency linked to hair thinning Diffuse thinning Monitor B12 per MHRA guidance; supplement if deficient
GLP-1 receptor agonists (e.g. semaglutide) / rapid weight loss Alopecia listed as adverse reaction in SmPC; rapid weight loss triggers telogen effluvium Telogen effluvium; diffuse shedding Discuss with prescriber; report via MHRA Yellow Card Scheme
Psychological stress Chronic stress from living with diabetes is a recognised trigger for telogen effluvium Telogen effluvium (often self-limiting, 3–6 months) Stress management; NHS Talking Therapies referral if needed

The Role of Blood Sugar, Circulation and Hair Growth

Chronically elevated blood glucose can damage small blood vessels and increase oxidative stress, potentially impairing scalp blood flow and pushing hair follicles prematurely into the shedding phase.

Chronically elevated blood glucose levels — a hallmark of poorly controlled diabetes — can damage small blood vessels throughout the body in a process known as microvascular disease. It is plausible that this damage may reduce blood flow to peripheral tissues, including the scalp, potentially compromising hair follicle function; however, direct clinical evidence specifically linking scalp microvascular impairment to hair loss in diabetes remains limited. Hair follicles depend on an adequate blood supply to receive oxygen and essential nutrients, so impaired circulation is considered a possible contributing factor to hair thinning.

High blood sugar is also associated with a state of oxidative stress, in which an excess of free radicals may damage cells and tissues. Hair follicle cells are thought to be vulnerable to oxidative damage, which could shorten the anagen (active growth) phase and push more follicles prematurely into the telogen (shedding) phase — a pattern of diffuse hair loss known as telogen effluvium. It is worth noting that telogen effluvium can also be triggered by acute illness, surgery, or rapid weight loss, all of which may occur in the context of diabetes management.

Insulin resistance — a core feature of type 2 diabetes — may also influence the hormonal environment that supports healthy hair growth. There is evidence, particularly in conditions such as polycystic ovary syndrome (PCOS), that insulin resistance can be associated with elevated androgen levels (such as dihydrotestosterone, DHT), which are a recognised driver of androgenetic alopecia (pattern hair loss). This androgen-related mechanism is most relevant where there are clinical features of hyperandrogenism. It should be noted that men with type 2 diabetes may have lower, rather than higher, total testosterone levels, so the picture is not straightforward. Achieving better glycaemic control, as guided by NICE NG28 (type 2 diabetes in adults) and NICE NG17 (type 1 diabetes in adults), may have an indirect positive effect on overall metabolic health, which in turn may support hair health.

Further information: NHS: Diabetes complications; NICE NG28: Type 2 diabetes in adults; NICE NG17: Type 1 diabetes in adults; NICE CKS: Polycystic ovary syndrome; British Association of Dermatologists: Telogen effluvium patient leaflet.

Thyroid dysfunction, vitamin B12 deficiency from metformin, alopecia areata, GLP-1 receptor agonist side effects, and psychological stress are all additional diabetes-related factors that can contribute to hair loss.

Beyond blood sugar and circulation, several other factors associated with diabetes may contribute to hair loss:

  • Thyroid dysfunction: People with type 1 diabetes have a higher prevalence of autoimmune thyroid conditions such as Hashimoto's thyroiditis. Both hypothyroidism and hyperthyroidism are well-established causes of diffuse hair loss, and thyroid function should be considered when investigating hair loss in people with diabetes.

  • Nutritional considerations: Rather than diabetes broadly impairing absorption of multiple micronutrients, the most clinically relevant nutritional risk is vitamin B12 deficiency in people taking long-term metformin. The MHRA has issued advice recommending that B12 levels be monitored in patients on metformin, particularly those on higher doses or with longer duration of use, as B12 deficiency has been linked to hair thinning. Additionally, people with type 1 diabetes have an increased risk of coeliac disease (another autoimmune condition), which can cause iron deficiency and associated hair shedding; coeliac screening should be considered where clinically indicated. If blood tests reveal specific deficiencies, your GP or a registered dietitian can advise on appropriate supplementation. Important: high-dose biotin (vitamin B7) supplements, sometimes taken for hair health, can interfere with a range of laboratory tests — including thyroid function and cardiac biomarker assays — and you should always inform your clinician if you are taking biotin before having blood tests.

  • Alopecia areata: Type 1 diabetes is an autoimmune condition, and individuals with one autoimmune disorder are at increased risk of developing others. Alopecia areata — in which the immune system attacks hair follicles, causing patchy hair loss — occurs more frequently in people with type 1 diabetes than in the general population.

  • Medication considerations: Some medicines used to manage diabetes or its complications may be associated with hair changes. Metformin does not have a confirmed causal link to hair loss, but long-term use can reduce vitamin B12 absorption (see above). Some GLP-1 receptor agonists used for type 2 diabetes or weight management (such as semaglutide) list alopecia as an adverse reaction in their product information; rapid weight loss associated with these or other treatments can also precipitate telogen effluvium. Always discuss any concerns about medication side effects with your prescriber before making any changes, and report suspected adverse reactions via the MHRA Yellow Card Scheme (yellowcard.mhra.gov.uk or the Yellow Card app).

  • Psychological stress: Living with a chronic condition such as diabetes can contribute to psychological stress, which is itself a recognised trigger for telogen effluvium.

Further information: MHRA Drug Safety Update: Metformin and reduced vitamin B12 levels; MHRA Drug Safety Update: Biotin interference with laboratory tests; Electronic Medicines Compendium (EMC) SmPC: Metformin; NICE CKS: Alopecia areata; NICE NG20: Coeliac disease; EMA EPAR: Wegovy (semaglutide 2.4 mg).

When to Speak to Your GP About Hair Loss

You should contact your GP if hair loss is sudden, patchy, accompanied by other symptoms, or affecting your mental wellbeing, as blood tests can identify treatable underlying causes.

Some daily hair shedding is entirely normal. However, certain patterns or features warrant prompt medical attention. If you have diabetes and are experiencing hair loss, you should contact your GP if:

  • Hair loss is sudden or rapid, or you are losing hair in distinct patches

  • Shedding has increased noticeably over a period of weeks or months

  • Hair loss is accompanied by other symptoms, such as fatigue, unexplained weight changes, skin changes, or mood disturbance — which may suggest an underlying thyroid or nutritional issue

  • Your scalp is inflamed, itchy, or scaly, which could indicate a dermatological condition requiring specialist assessment

  • There is scalp pain or tenderness, persistent redness, scaling with loss of follicular openings, or rapidly progressive areas of scarring — these are red flags for possible scarring alopecia and warrant urgent dermatology review

  • Hair loss is affecting your mental wellbeing or quality of life

Your GP may arrange blood tests to investigate potential contributing causes, including:

  • Full blood count (to check for anaemia)

  • Thyroid function tests (TSH, free T4)

  • Ferritin and iron studies

  • Vitamin B12, folate, and vitamin D levels

  • HbA1c (to assess recent glycaemic control)

  • Coeliac serology (tissue transglutaminase IgA with total IgA) — particularly in type 1 diabetes, unexplained iron deficiency, or where symptoms suggest coeliac disease

  • Androgen levels (total testosterone, SHBG/free androgen index) — in women with clinical features of hyperandrogenism such as hirsutism, acne, or menstrual irregularity

Depending on findings, your GP may refer you to a dermatologist or endocrinologist, or adjust your diabetes management plan. Early investigation is preferable, as some causes of hair loss are more readily reversible when identified promptly.

Further information: NHS: Hair loss (Alopecia); NICE CKS: Telogen effluvium; NICE CKS: Female pattern hair loss; NICE NG20: Coeliac disease.

Managing Hair Loss Alongside Diabetes

Optimising blood glucose control is the most effective approach; topical minoxidil is a licensed over-the-counter option for androgenetic alopecia, and telogen effluvium often resolves within three to six months once the trigger is addressed.

The most effective approach to managing diabetes-related hair loss is to address the underlying metabolic factors driving it. Optimising blood glucose control remains central to this. Following NICE-recommended targets for HbA1c, maintaining a balanced diet, engaging in regular physical activity, and adhering to prescribed medications all contribute to reducing the vascular and hormonal disruptions that may impair hair growth.

Nutritional support is also important. A diet rich in lean proteins, leafy green vegetables, nuts, seeds, and whole grains provides the building blocks — including amino acids, iron, zinc, and B vitamins — that hair follicles require. If blood tests reveal specific deficiencies, your GP or a registered dietitian may recommend targeted supplementation. It is advisable to avoid self-prescribing high-dose supplements without professional guidance, as some can interfere with diabetes medications, glucose regulation, or laboratory test results. In particular, inform your clinician if you are taking biotin supplements, as these can interfere with a range of blood tests (see MHRA guidance).

Telogen effluvium — diffuse shedding triggered by illness, surgery, rapid weight loss, or metabolic disruption — is often self-limiting and typically improves within three to six months once the underlying trigger has been addressed. Knowing this can provide reassurance whilst investigations are under way.

For those with confirmed androgenetic alopecia, topical minoxidil (available over the counter in the UK) is a licensed treatment that can slow hair loss and promote regrowth in both men and women. Practical points to be aware of:

  • Use consistently for at least six months before assessing benefit, as results take time

  • An initial increase in shedding may occur in the first few weeks; this is usually temporary

  • Local scalp irritation (dryness, itching, or redness) is a common side effect

  • Avoid use during pregnancy or breastfeeding — consult your GP or pharmacist for advice

  • Always read the Summary of Product Characteristics (SmPC) or patient information leaflet before use; oral minoxidil should only be used under specialist supervision

  • Report any suspected adverse reactions to the MHRA Yellow Card Scheme

For alopecia areata, treatment options include topical or intralesional corticosteroids, and referral to a dermatologist is typically recommended.

Stress management should not be overlooked. Techniques such as mindfulness, structured exercise, and access to psychological support can help reduce stress-related hair shedding. In England, NHS Talking Therapies offers free psychological support; equivalent services are available through NHS Scotland, NHS Wales, and the Health and Social Care Board in Northern Ireland. Diabetes UK also offers peer support networks that many people find beneficial for overall wellbeing.

Further information: Electronic Medicines Compendium (EMC) SmPC: Minoxidil topical (UK); MHRA Drug Safety Update: Biotin interference with laboratory tests; NICE NG28 and NG17; NHS: Hair loss (Alopecia).

Your GP or diabetes care team is the first point of contact; NHS.uk, Diabetes UK, Alopecia UK, and the MHRA Yellow Card Scheme all provide relevant support and information.

If you are concerned about hair loss in the context of diabetes, a range of NHS and reputable UK resources are available to support you:

  • Your GP or diabetes care team should be your first point of contact. They can coordinate investigations, review your current management plan, and refer you to appropriate specialists such as a dermatologist or endocrinologist.

  • NHS.uk provides accessible, evidence-based information on both diabetes management and hair loss, including guidance on when to seek medical advice (see: nhs.uk/conditions/hair-loss and nhs.uk/conditions/diabetes).

  • NICE guidelines — particularly NG28 (type 2 diabetes in adults) and NG17 (type 1 diabetes in adults) — outline best-practice standards for diabetes care in England and Wales, including targets for glycaemic control that underpin overall health.

  • NICE Clinical Knowledge Summaries (CKS) provide clinician-facing guidance on telogen effluvium, female pattern hair loss, and alopecia areata, and are a useful reference for understanding how hair loss is assessed and managed in UK primary care.

  • Diabetes UK (diabetes.org.uk) is the leading UK charity for people living with diabetes. It offers helplines, online communities, dietary advice, and information on managing the wider health impacts of diabetes.

  • Alopecia UK (alopecia.org.uk) provides dedicated support for individuals experiencing hair loss, including those with autoimmune-related alopecia areata.

  • The British Association of Dermatologists (bad.org.uk) offers patient information leaflets on androgenetic alopecia, telogen effluvium, and alopecia areata, and can help you understand what to expect from a dermatology referral.

  • MHRA Yellow Card Scheme (yellowcard.mhra.gov.uk or the Yellow Card app): If you suspect that a medicine — including a diabetes treatment or a hair loss product — is causing an adverse reaction, you can report this directly to the MHRA. You do not need to be certain; suspicion is sufficient. Your report helps improve medicine safety for everyone.

Remember that hair loss, whilst often distressing, is frequently manageable once the contributing factors are identified and addressed. Working collaboratively with your healthcare team — and keeping your diabetes well controlled — gives you the best chance of maintaining both your overall health and your hair.

Frequently Asked Questions

Can getting my diabetes under better control help my hair grow back?

Improving glycaemic control can help address some of the underlying mechanisms — such as poor circulation and oxidative stress — that may be contributing to hair loss in diabetes. If the hair loss is due to telogen effluvium triggered by metabolic disruption, it often improves within three to six months once the trigger is resolved, though results vary depending on the cause.

Is hair loss a side effect of metformin?

Metformin does not have a confirmed direct causal link to hair loss, but long-term use can reduce vitamin B12 absorption, and B12 deficiency is associated with hair thinning. The MHRA recommends that B12 levels are monitored in patients on long-term metformin, particularly at higher doses, so speak to your GP if you are concerned.

What is the difference between telogen effluvium and alopecia areata in people with diabetes?

Telogen effluvium is diffuse, generalised shedding triggered by metabolic stress, illness, or nutritional deficiency, and is often temporary and reversible. Alopecia areata is an autoimmune condition causing distinct patchy hair loss, and is more common in people with type 1 diabetes due to their increased susceptibility to autoimmune disorders; it typically requires dermatology assessment and specific treatment.

Can semaglutide or other weight-loss injections cause hair loss?

Yes — GLP-1 receptor agonists such as semaglutide list alopecia as an adverse reaction in their product information, and rapid weight loss associated with these treatments can also trigger telogen effluvium. If you notice increased hair shedding after starting a GLP-1 medication, discuss this with your prescriber and consider reporting it via the MHRA Yellow Card Scheme.

Should I take biotin supplements to help with diabetes-related hair loss?

High-dose biotin supplements are not recommended without professional guidance, as they can interfere with a range of blood tests — including thyroid function and cardiac biomarker assays — which could affect your diabetes monitoring. Always inform your GP or clinician if you are taking biotin before having any blood tests, and seek advice on whether supplementation is appropriate for your specific situation.

How do I get treatment for hair loss on the NHS if I have diabetes?

Start by speaking to your GP, who can arrange blood tests to identify treatable causes such as thyroid dysfunction, B12 deficiency, or iron deficiency, and may refer you to a dermatologist or endocrinologist if needed. Topical minoxidil for androgenetic alopecia is available over the counter in the UK without a prescription, though NHS prescribing criteria apply for other treatments.


Disclaimer & Editorial Standards

The health-related content published on this site is based on credible scientific sources and is periodically reviewed to ensure accuracy and relevance. Although we aim to reflect the most current medical knowledge, the material is meant for general education and awareness only.

The information on this site is not a substitute for professional medical advice. For any health concerns, please speak with a qualified medical professional. By using this information, you acknowledge responsibility for any decisions made and understand we are not liable for any consequences that may result.

Any third-party brands or services referenced on this site are included for informational purposes only; we are entirely independent and have no affiliation, partnership, or collaboration with any companies mentioned.

Heading 1

Heading 2

Heading 3

Heading 4

Heading 5
Heading 6

Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat. Duis aute irure dolor in reprehenderit in voluptate velit esse cillum dolore eu fugiat nulla pariatur.

Block quote

Ordered list

  1. Item 1
  2. Item 2
  3. Item 3

Unordered list

  • Item A
  • Item B
  • Item C

Text link

Bold text

Emphasis

Superscript

Subscript

Book a discovery call

and discuss your eligibility for the Fella Program

Book your free call